Vitalograph

Vitalograph is a global leader in respiratory diagnostic products and clinical trial services, established in 1963 in the UK. The company specializes in manufacturing high-quality spirometers and other medical devices that assist in the detection, diagnosis, and management of respiratory conditions such as asthma, COPD, and cystic fibrosis. Its product range includes spirometers, lung and asthma monitors, COPD screeners, medical workstations, software, and consumables, all known for their reliable measuring technology and fast, accurate results. In addition to its medical devices, Vitalograph offers clinical trial services to pharmaceutical companies, biotech firms, and contract research organizations, supporting the development of respiratory therapies. The company is recognized for providing FDA-validated objective cough monitoring, a unique service in the industry. With operations in the UK, Ireland, Germany, Japan, and the USA, Vitalograph is dedicated to advancing respiratory health through research, sustainability initiatives, and support for lung disease research in low-income countries. Its customers include healthcare professionals, occupational health providers, and clinical research organizations focused on improving patient outcomes.

• Employees 330
• Founded 1963
• Annual Revenue $115700000